AMPHENOL /DE/ (APH) SEC Filings, Oct-Nov 2025

Amphenol (APH) reported insider activity by an officer on 10/31/2025. The filer exercised 120,000 stock options at $22 per share and sold 120,000 Class A shares at a $141.3032 weighted average price, executed in multiple trades between $140.85 and $141.5701. Following these transactions, the officer directly owned 152,412 shares. Indirect holdings were 2,995 shares by children and 1,700 by spouse.

Amphenol (APH) received a Rule 144 notice for a proposed sale of 120,000 shares of Common Stock through Morgan Stanley Smith Barney LLC on 10/31/2025 on the NYSE. The filing lists an aggregate market value of $16,956,384 for the shares to be sold.

The shares were acquired on 10/31/2025 via exercise of options under a registered plan, paid in cash. The notice also reports a sale during the past three months by Michael Ivas of 50,000 shares on 08/08/2025 for $5,500,820. Shares outstanding were 1,224,055,508.

Amphenol (APH) insider transaction: An officer identified as President, CS Division reported an option exercise and same‑day sale on 10/29/2025. The filing shows an exercise of 80,000 stock options at an exercise price of $33.295 per share (code M), followed by an open market sale of 80,000 Class A Common shares (code S) at a $141.0366 weighted average price, with trades ranging from $141.00 to $141.1550.

Following these transactions, the filing lists 0 non‑derivative shares beneficially owned and 186,000 derivative securities (stock options) beneficially owned. The stock option series exercised was originally exercisable on 05/20/2022 and expires on 05/20/2031.

Amphenol (APH) reported an insider transaction by its President & CEO and Director on 10/28/2025. The filing shows a bona fide gift of 75,000 Class A Common shares (Code G), and an option exercise (Code M) for 75,000 shares at an exercise price of $22.3725 per share. Following these transactions, the reporting person directly owned 2,002,507 shares. Additional holdings include 864,177 shares held indirectly by the Norwitt Family Trust and 3,968 shares held directly through an IRA. The closing price on the gift date was $137.29.

Amphenol (APH): On 10/29/2025, Sr. VP, Secretary & General Counsel Lance E. D'Amico exercised stock options for 120,000 Class A shares at $22.5525 (code M) and sold 120,000 shares at a weighted average price of $140.0129 (code S), executed across trades ranging from $139.71 to $140.53.

Following these transactions, he directly owned 76,400 shares and indirectly held 25,000 shares via the Lance E. D'Amico 2025 GRAT #1. The exercised options were from a grant first exercisable on 05/21/2021 and expiring on 05/21/2030; 100,000 stock options remained beneficially owned.

The Vanguard Group filed an amended Schedule 13G reporting beneficial ownership of 125,227,087 shares of Amphenol Corp (APH) common stock, representing 10.25% of the class as of 09/30/2025.

Vanguard reported 0 shares with sole voting power and 7,332,606 shares with shared voting power. It reported 113,675,172 shares with sole dispositive power and 11,551,915 shares with shared dispositive power. Vanguard certified the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control.

APH — Form 144 notice of proposed sale. A holder filed to sell 120,000 common shares through Morgan Stanley Smith Barney LLC on the NYSE, with an aggregate market value of $16,801,548.00. The issuer had 1,224,055,508 shares outstanding as of the notice. The approximate sale date is 10/29/2025.

The shares to be sold were acquired on 10/29/2025 via exercise of options under a registered plan, with payment in cash. In the past three months, related sales reported include 30,000 shares for $3,324,249.00 by LANCE E D'AMICO 2024 IRRV TRUST and 100,000 shares for $11,060,030.00 by LANCE D AMICO on 08/18/2025.

This notice states the seller does not know of undisclosed material adverse information.

Amphenol (APH): Shareholder files Form 144 notice to sell stock. A holder named William Doherty filed to sell up to 80,000 shares of Amphenol common stock through Morgan Stanley Smith Barney LLC on or about 10/29/2025. The filing lists an aggregate market value of $11,282,928 for the proposed sale and identifies the NYSE as the exchange.

The shares were acquired on 10/29/2025 via the exercise of options under a registered plan, paid in cash. The filing also reports recent activity over the past three months: 113,000 shares sold on 08/11/2025 for gross proceeds of $12,462,837.80 and 113,000 shares sold on 08/08/2025 for gross proceeds of $12,304,750.80.

Amphenol Corporation launched a primary debt offering of $7.5 billion in senior notes across seven tranches to help finance its planned $10.5 billion cash acquisition of CommScope’s Connectivity and Cable Solutions businesses. Tranches include $500 million floating-rate notes due 2027 at Compounded SOFR + 0.53%, plus fixed-rate notes: $750 million 3.800% due 2027, $750 million 3.900% due 2028, $1.0 billion 4.125% due 2030, $1.25 billion 4.400% due 2033, $1.6 billion 4.625% due 2036, and $1.65 billion 5.300% due 2055.

The company expects approximately $7,431.8 million in net proceeds, to be combined with cash on hand and potential borrowings under delayed draw term loans and/or its U.S. commercial paper program to fund the acquisition and related fees. The offering is not conditioned on closing the deal. If the acquisition is not completed by the specified date or is abandoned, all series are subject to a special mandatory redemption at 101% of principal plus accrued interest. The notes are unsecured senior obligations, include a 101% repurchase upon a Change of Control Repurchase Event, and settle on a T+10 basis.